
Advanced Mold Development

Advanced Mold Building Developments
RenyMed continues to invest in advanced mold building technologies that enhance flexibility, reduce lead times, and support the evolving needs of medical device manufacturing. Our forward-thinking approach to mold design and construction helps streamline development cycles and supports rapid scale-up without sacrificing quality or performance.
Modular, Building-Block Approach to Mold Design
We utilize a modular, building-block methodology in our mold design and construction processes. This approach allows us to develop tools using standardized, interchangeable components, which can be quickly configured or adapted to meet changing part designs or project requirements. This design strategy increases flexibility, reduces custom machining time, and shortens overall tool build timelines, especially beneficial during early-stage development and rapid prototyping.


Stocked Modular Components for Faster Turnaround
To support accelerated production timelines, we maintain an inventory of pre-fabricated modular mold components. By having critical components readily available, we can drastically reduce delivery time for prototype and bridge tooling, helping our customers meet tight regulatory deadlines and product launch windows with confidence.

Direct Drive Unscrewing Technology
For parts requiring internal threads or complex part-release mechanics, we offer direct drive unscrewing technology as part of our tooling capabilities. This advanced mechanism allows for precise, reliable demolding of threaded features without compromising cycle time or tool longevity. Direct drive systems offer better control, reduced wear, and a more compact design compared to traditional unscrewing mechanisms, making them ideal for high-cavity, high-speed production of intricate medical components.
By combining modular flexibility with cutting-edge mold mechanics, RenyMed provides its partners with adaptable, efficient tooling solutions that evolve with their products, whether they’re iterating in R&D or ramping up for commercial production.
